1 |
Lu Y, Bao JG, Deng Y, et al (2015). Role of IL-18 gene promoter polymorphisms, serum il-18 levels, and risk of hepatitis b virus-related liver disease in the guangxi zhuang population: a retrospective case-control study. Asian Pac J Cancer Prev, 16, 6019-26.
DOI
|
2 |
Malaguarnera M, Di Fazio I, Laurino A, et al (1997). Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-alpha treatment. Int J Clin Pharmacol Ther, 35, 385-8.
|
3 |
Mansoori M, Golalipour M, Alizadeh S, et al (2015). Genetic variation in the ABCB1 gene may lead to mRNA level chabge: application to gastric cancer cases. asian pac j cancer prev, 16, 8467-71.
|
4 |
Merat S, Malekzadeh R, Rezvan H, et al (2000). Hepatitis B in Iran. Arch Iran Med, 3, 192-201.
|
5 |
Migita K, Miyazoe S, Maeda Y, et al (2005). Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF- polymorphisms and hepatocellular carcinoma. J Hepatol, 42, 505-10.
DOI
|
6 |
Nattermann J, Vogel M, Berg T, et al (2007). Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients. Hepatol, 46, 1016-25.
DOI
|
7 |
Nun-Anan P, Chonprasertsuk S, Siramolpiwat S, et al (2015). CYP2C19 genotype could be a predictive factor for aggressive manifestations of hepatocellular carcinoma related with chronic hepatitis B infection in Thailand. Asian Pac J Cancer Prev, 16, 3253-6.
DOI
|
8 |
Park BL, Lee HS, Kim YJ, et al (2003). Association between interleukin 6 promoter variants and chronic hepatitis B progression. Exp Mol Med, 35, 76-82.
DOI
|
9 |
Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
DOI
|
10 |
Pourhoseingholi MA, Fazeli Z, Zali MR, et al (2010). Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend analysis. Asian Pac J Cancer Prev, 11, 859-62.
|
11 |
Rapicetta M, Ferrari C, Levrero M (2002). Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol, 67, 454-7.
DOI
|
12 |
Shahbazi M, Ebadi H, Fathi D, et al (2010). HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. Mult Scler, 16, 1173-7.
DOI
|
13 |
Shahbazi M, Pravica V, Nasreen N, et al (2002). Association between functional polymorphism in EGF gene and malignant melanoma. Lancet, 359, 397-401.
DOI
|
14 |
Shamszad M, Farzadegan H (1982). Hepatitis B related cirrhosis and hepatocellular carcinoma in Iran. J Irn Med Council, 8, 238.
|
15 |
Wang C, Tang J, Song W, et al (2004). HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatol, 39, 978-88.
DOI
|
16 |
Song W, Zhang F, Li Z (2000). [A quantitative analysis of IL-6 mRNA expression of peripheral blood monocyte cell in patients with chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi, 8, 346-7.
|
17 |
Tayebi S, Mohamadkhani A (2012). The TNF-alpha -308 promoter gene polymorphism and chronic HBV infection. Hepat Res Treat, 2012, 493219.
|
18 |
Terry CF, Loukaci V, Green FR (2000). Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem, 275, 18138-44.
DOI
|
19 |
Wang CH, Wey KC, Mo LR, et al (2015). Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. Asian Pac J Cancer Prev, 16, 3595-604.
DOI
|
20 |
Ben-Ari Z, Mor E, Papo O, et al (2003). Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol, 98, 144-50.
DOI
|
21 |
Fallot G, Neuveut C, Buendia MA (2012). Diverse roles of hepatitis B virus in liver cancer. Curr Opin Virol, 2, 467-73.
DOI
|
22 |
Colombo M, Kuo G, Choo QL, et al (1989). Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet, 2, 1006-8.
|
23 |
Cussigh A, Falleti E, Fabris C, et al (2011). Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. Immunogenetics, 63, 33-41.
DOI
|
24 |
Fabris C, Toniutto P, Bitetto D, et al (2009). Gene polymorphism at the interleukin 6 -174 G > C locus affects the outcome of chronic hepatitis B. J Infect, 59, 144-5.
DOI
|
25 |
Fernandez-Real JM, Broch M, Vendrell J, et al (2000). Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes, 49, 517-20.
DOI
|
26 |
Fishman D, Faulds G, Jeffery R, et al (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 102, 1369-76.
DOI
|
27 |
Galun E, Nahor O, Eid A, et al (2000). Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. Virol, 270, 299-309.
DOI
|
28 |
Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52.
DOI
|
29 |
Chanthra N, Payungporn S, Chuaypen N, et al (2015). Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B. Asian Pac J Cancer Prev, 16, 8405-10.
|
30 |
Capurso C, Solfrizzi V, D'Introno A, et al (2004). Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp Gerontol, 39, 1567-73.
DOI
|
31 |
Kumar V, Abbas AK, Fausto N, et al (2014). Robbins and cotran pathologic basis of disease, elsevier health sciences.
|
32 |
Jeng JE, Wu HF, Tsai MF, et al (2014). Independent and additive interaction between tumor necrosis factor beta +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study. Asian Pac J Cancer Prev, 15, 10209-15.
|
33 |
Kakumu S, Shinagawa T, Ishikawa T, et al (1993). Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol Jpn, 28, 18-24.
DOI
|
34 |
Kim YJ, Lee HS, Yoon JH, et al (2003). Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet, 12, 2541-6.
DOI
|
35 |
Kummee P, Tangkijvanich P, Poovorawan Y, et al (2007). Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat, 14, 841-8.
|
36 |
Li N, Gao YF, Zhang TC, et al (2012). Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol, 4, 105-9.
DOI
|
37 |
Limothai U, Wasitthankasem R, Poovorawan Y, et al (2015). Single nucleotide polymorphism of interferon lambda-4 gene is not associated with treatment response to pegylated interferon in thai patients with chronic hepatitis B. Asian Pac J Cancer Prev, 16, 5515-9.
DOI
|
38 |
Hajiani E, Masjedizadeh R, Hashemi J, et al (2005). Risk factors for hepatocellular carcinoma in Southern Iran. Saudi Med J, 26, 974-7.
|
39 |
Hamid YH, Rose CS, Urhammer SA, et al (2005). Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia, 48, 251-60.
DOI
|